These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1968584)

  • 41. A case-control study of diabetic end-stage renal disease in Nebraska.
    Rettig BA; Klein DK; Teutsch SM; Langford D
    Nebr Med J; 1985 Oct; 70(10):370-3. PubMed ID: 4047233
    [No Abstract]   [Full Text] [Related]  

  • 42. The mechanisms underlying altered vascular resistance of glomerular afferent and efferent arterioles in diabetic nephropathy.
    Arima S; Ito S
    Nephrol Dial Transplant; 2003 Oct; 18(10):1966-9. PubMed ID: 13679465
    [No Abstract]   [Full Text] [Related]  

  • 43. [Glomerular diseases and diabetes mellitus].
    Hara S; Nihei H; Mimura N
    Nihon Rinsho; 1984 Jun; 42(6):1411-7. PubMed ID: 6482006
    [No Abstract]   [Full Text] [Related]  

  • 44. De novo diabetic nephropathy with functional impairment in a renal allograft.
    Gimenez LF; Watson AJ; Burrow CR; Olson JL; Klassen DK; Cooke CR
    Am J Nephrol; 1986; 6(5):378-81. PubMed ID: 3548353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glomerular hemodynamics in progressive renal disease.
    Ofstad J; Horvei G; Kvam FI; Mørkrid L; Sekse I; Svarstad E; Iversen BM
    Kidney Int Suppl; 1992 May; 36():S8-14. PubMed ID: 1614073
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hyperfiltration nephropathy].
    Praga M
    Nefrologia; 2000; 20(4):311-35. PubMed ID: 11039257
    [No Abstract]   [Full Text] [Related]  

  • 47. Haemostatic activation and proteinuria as factors in the progression of chronic renal failure.
    Gordge MP; Leaker BR; Rylance PB; Neild GH
    Nephrol Dial Transplant; 1991; 6(1):21-6. PubMed ID: 2057112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical manifestations and natural history of diabetic kidney disease.
    Ritz E
    Med Clin North Am; 2013 Jan; 97(1):19-29. PubMed ID: 23290727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular endothelial growth factor and diabetic nephropathy.
    Gudehithlu KP; Singh AK
    Int J Artif Organs; 1999 May; 22(5):297-9. PubMed ID: 10467926
    [No Abstract]   [Full Text] [Related]  

  • 50. [Early renal hemodynamic modifications during diabetes mellitus: physiopathologic mechanisms].
    Hannedouche T; Boitard C; Delgado A; Gnionsahe A; Lazaro M; Assan R; Grünfeld JP
    Journ Annu Diabetol Hotel Dieu; 1989; ():213-24. PubMed ID: 2668615
    [No Abstract]   [Full Text] [Related]  

  • 51. Pathophysiology of diabetic nephropathy: involvement of multifaceted signalling mechanism.
    Balakumar P; Arora MK; Reddy J; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):129-38. PubMed ID: 19528810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity and chronic kidney disease.
    Kopple JD
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S29-30. PubMed ID: 20797567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. End-stage renal disease in people with type 2 diabetes: systemic manifestations and exercise implications.
    Evans N; Forsyth E
    Phys Ther; 2004 May; 84(5):454-63. PubMed ID: 15113278
    [No Abstract]   [Full Text] [Related]  

  • 54. Risk of diabetic nephropathy in potential living related kidney donors.
    Simmons D; Searle M
    BMJ; 1998 Mar; 316(7134):846-8. PubMed ID: 9549459
    [No Abstract]   [Full Text] [Related]  

  • 55. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration.
    Thomson SC; Vallon V; Blantz RC
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F8-15. PubMed ID: 14656757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Functional glomerular microangiopathy].
    Mogensen CE
    Journ Annu Diabetol Hotel Dieu; 1979; ():19-34. PubMed ID: 502125
    [No Abstract]   [Full Text] [Related]  

  • 57. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients.
    Steffes MW; Osterby R; Chavers B; Mauer SM
    Diabetes; 1989 Sep; 38(9):1077-81. PubMed ID: 2670639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The role of intraglomerular hypertension and lipids in the development of diabetic nephropathy].
    Shestakova MV; Neverov NI; Dedov II
    Ter Arkh; 1993; 65(6):61-5. PubMed ID: 8378853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diabetic nephropathy. Pathogenetic, diagnostic and therapeutic concepts].
    Kleophas W; Voitz T; Messner H; Gries FA
    Fortschr Med; 1990 May; 108(16):309-12. PubMed ID: 2204599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of progression of macrovascular diseases after kidney or pancreas and kidney transplantation in diabetic patients with end-stage renal disease.
    Biesenbach G; Margreiter R; Königsrainer A; Bösmüller C; Janko O; Brücke P; Gross C; Zazgornik J
    Diabetologia; 2000 Feb; 43(2):231-4. PubMed ID: 10753046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.